HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia.

Abstract
Dominant mutations in the gamma2 regulatory subunit of AMP-activated protein kinase (AMPK), encoded by the gene PRKAG2, cause glycogen storage cardiomyopathy. We sought to elucidate the effect of the Thr400Asn (T400N) human mutation in a transgenic mouse (TGT400N) on AMPK activity, and its ability to protect the heart against ischemia-reperfusion injury. TGT400N hearts had markedly vacuolated myocytes, excessive accumulation of glycogen, hypertrophy, and preexcitation. Early activation of myocardial AMPK, followed by depression, and then recovery to wild-type levels was observed. AMPK activity correlated inversely with glycogen content. Partial rescue of the phenotype was observed when TGT400N mice were crossbred with TGalpha2DN mice, which overexpress a dominant negative mutant of the AMPK alpha2 catalytic subunit. TGT400N hearts had greater infarct sizes and apoptosis when subjected to ischemia-reperfusion. Increased AMPK activity is responsible for glycogen storage cardiomyopathy. Despite high glycogen content, the TGT400N heart is not protected against ischemia-reperfusion injury.
AuthorsSanjay K Banerjee, Ravi Ramani, Samir Saba, Jennifer Rager, Rong Tian, Michael A Mathier, Ferhaan Ahmad
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 360 Issue 2 Pg. 381-7 (Aug 24 2007) ISSN: 0006-291X [Print] United States
PMID17597581 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cardiotonic Agents
  • Multienzyme Complexes
  • Glycogen
  • PRKAA2 protein, human
  • Protein Serine-Threonine Kinases
  • AMP-Activated Protein Kinases
Topics
  • AMP-Activated Protein Kinases
  • Animals
  • Cardiotonic Agents
  • Enzyme Activation
  • Glycogen (metabolism)
  • Humans
  • Mice
  • Mice, Transgenic
  • Multienzyme Complexes (genetics, metabolism)
  • Mutation
  • Myocardial Reperfusion Injury (genetics, metabolism, pathology)
  • Myocardium (metabolism, pathology)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: